PU.1 Activation Relieves GATA-1-Mediated Repression of Cebpa and Cbfb during Leukemia Differentiation

被引:21
|
作者
Burda, Pavel [1 ,2 ]
Curik, Nikola [1 ,2 ]
Kokavec, Juraj [1 ,2 ]
Basova, Petra [1 ,2 ]
Mikulenkova, Dana [3 ]
Skoultchi, Arthur I. [5 ]
Zavadil, Jiri [6 ,7 ]
Stopka, Tomas [1 ,2 ,4 ]
机构
[1] Charles Univ Prague, Fac Med 1, Inst Pathol Physiol, Prague 12853, Czech Republic
[2] Charles Univ Prague, Fac Med 1, Ctr Expt Hematol, Prague 12853, Czech Republic
[3] Gen Fac Hosp, Inst Hematol & Blood Transfus, Prague, Czech Republic
[4] Gen Fac Hosp, Dept Med 1, Prague, Czech Republic
[5] Albert Einstein Coll Med, Dept Cell Biol, Bronx, NY 10467 USA
[6] NYU, Dept Pathol, Inst Canc, New York, NY 10016 USA
[7] New York Langone Med Ctr, Ctr Hlth Informat & Bioinformat, Prague, Czech Republic
关键词
ACUTE MYELOID-LEUKEMIA; TRANSCRIPTION FACTOR; TERMINAL DIFFERENTIATION; BETA-SUBUNIT; C/EBP-ALPHA; GATA-1; CELLS; EXPRESSION; BINDING; HEMATOPOIESIS;
D O I
10.1158/1541-7786.MCR-09-0031
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Hematopoietic transcription factors GATA-1 and PU.1 bind each other on DNA to block transcriptional programs of undesired lineage during hematopoietic commitment. Murine erythroleukemia (MEL) cells that coexpress GATA-1 and PU.1 are blocked at the blast stage but respond to molecular removal (down regulation) of PU.1 or addition (upregulation) of GATA-1 by inducing terminal erythroid differentiation. To test whether GATA-1 blocks PU.1 in MEL cells, we have conditionally activated a transgenic PU.1 protein fused with the estrogen receptor ligand-binding domain (PUER), resulting in activation of a myeloid transcriptional program. Gene expression arrays identified components of the PU.1-dependent transcriptome negatively regulated by GATA-1 in MEL cells, including CCAAT/enhancer binding protein a (Cebpa) and core-binding factor, beta subunit (Cbfb), which encode two key hematopoietic transcription factors. Inhibition of GATA-1 by small interfering RNA resulted in derepression of PU.1 target genes. Chromatin immunoprecipitation and reporter assays identified PU.1 motif sequences near Cebpa and Cbfb that are co-occupied by PU.1 and GATA-1 in the leukemic blasts. Significant derepression of Cebpa and Cbfb is achieved in MEL cells by either activation of PU.1 or knockdown of GATA-1. Furthermore, transcriptional regulation of these loci by manipulating the levels of PU.1 and GATA-1 involves quantitative increases in a transcriptionally active chromatin mark: acetylation of histone H3K9. Collectively, we show that either activation of PU.1 or inhibition of GATA-1 efficiently reverses the transcriptional block imposed by GATA-1 and leads to the activation of a myeloid transcriptional program directed by PU.1. (Mol Cancer Res 2009;7(10):1693-703)
引用
收藏
页码:1693 / 1703
页数:11
相关论文
共 50 条
  • [41] Direct association between PU.1 and MeCP2 that recruits mSin3A-HDAC complex for PU.1-mediated transcriptional repression
    Mitsuhiro Suzuki
    Toshiyuki Yamada
    Fumiko Kihara-Negishi
    Takuya Sakurai
    Tsuneyuki Oikawa
    Oncogene, 2003, 22 : 8688 - 8698
  • [42] Combinatorial activation of the eosinophil major basic protein gene requires transcription factors C/EBPε, PU.1 and GATA-1.
    Gombart, AF
    Kwok, SH
    Yamaguchi, Y
    Koeffler, HP
    BLOOD, 2000, 96 (11) : 806A - 806A
  • [43] CLEC5A (MDL-1) is a novel PU.1 transcriptional target during myeloid differentiation
    Batliner, Jasmin
    Mancarelli, Maria Michela
    Jenal, Mathias
    Reddy, Venkateshwar A.
    Fey, Martin F.
    Torbett, Bruce E.
    Tschan, Mario P.
    MOLECULAR IMMUNOLOGY, 2011, 48 (04) : 714 - 719
  • [44] LSD1 inhibition by tranylcypromine derivatives interferes with GFI1-mediated repression of PU.1 target genes and induces differentiation in AML (vol 33, pg 1411, 2019)
    Barth, Jessica
    Abou-El-Ardat, Khalil
    Dalic, Denis
    Kurrle, Nina
    Maier, Anna-Maria
    Mohr, Sebastian
    Schuette, Judith
    Vassen, Lothar
    Greve, Gabriele
    Schulz-Fincke, Johannes
    Schmitt, Martin
    Tosic, Milica
    Metzger, Eric
    Bug, Gesine
    Khandanpour, Cyrus
    Wagner, Sebastian A.
    Luebbert, Michael
    Jung, Manfred
    Serve, Hubert
    Schuele, Roland
    Berg, Tobias
    LEUKEMIA, 2019, 33 (06) : 1541 - 1541
  • [45] A genome wide approach for identification of PU.1 target genes during macrophage differentiation.
    Laslo, P
    Sciammas, R
    Walsh, J
    Singh, H
    BLOOD, 2002, 100 (11) : 298A - 298A
  • [46] ROLE OF A TRANSCRIPTION FACTOR PU.1 IN TGF-B SIGNALING-MEDIATED OSTEOCLAST DIFFERENTIATION
    Ishiyama, K.
    Tamura, N.
    Yashiro, T.
    Nishiyama, C.
    Okumura, K.
    Takasaki, Y.
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 : 380 - 380
  • [47] Regulation of the TRAP promoter by MITF and PU.1 transcription factors during osteoclast differentiation.
    Luchin, AI
    Cassady, AI
    Hume, DA
    Ostrowski, MC
    MOLECULAR BIOLOGY OF THE CELL, 2000, 11 : 163A - 163A
  • [48] Aryl hydrocarbon receptor (AhR) activation perturbs myeloid sublineage differentiation by inhibiting PU.1 upregulation
    Richter, S.
    Platzer, B.
    Waltenberger, D.
    Woisetschlaeger, M.
    Strobl, H.
    WIENER KLINISCHE WOCHENSCHRIFT, 2008, 120 : 95 - 96
  • [49] Differentiation of the mononuclear phagocyte system during mouse embryogenesis: The role of transcription factor PU.1
    Lichanska, AM
    Browne, CM
    Henkel, GW
    Murphy, KM
    Ostrowski, MC
    McKercher, SR
    Maki, RA
    Hume, DA
    BLOOD, 1999, 94 (01) : 127 - 138
  • [50] Runx1 Regulation of Pu.1 Corepressor/Coactivator Exchange Identifies Specific Molecular Targets for Leukemia Differentiation Therapy
    Gu, Xiaorong
    Hu, Zhenbo
    Ebrahem, Quteba
    Crabb, John S.
    Mahfouz, Reda Z.
    Radivoyevitch, Tomas
    Crabb, John W.
    Saunthararajah, Yogen
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2014, 289 (21) : 14881 - 14895